Vanda Pharmaceuticals | VNDA - Ordinary Share Capital

Stock Price
7.26
Daily Change
0.44 6.45%
Monthly
-15.58%
Yearly
52.20%
Q1 Forecast
6.91

Vanda Pharmaceuticals reported $58K in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Anika Therapeutics USD 13.89M 532K Dec/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
J&J USD 2.41B 584K Sep/2025
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Takeda JPY 1.58B 2K Dec/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024
Veracyte USD 79.05M 377K Dec/2025